{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:45:12Z","timestamp":1786617912902,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maple Syrup Urine Disease (MSUD) disease is a defect in the function of the Branched-chain 2-ketoacid dehydrogenase complex (BCKDH). It is caused by pathogenic biallelic variants in BCKDHA, BCKA decarboxylase, or dihydrolipoamide dehydrogenase. The brain is the major organ involved in MSUD. MSUD happens in about 1 in 86,800 to 185,000 live births. According to some diversity in the management of Iranian patients with MSUD, the development of a national guideline is essential. This guideline is provided through a literature search on articles in PubMed, Scopus, Web of Sciences, Cochrane, and Embase databases from 2001 to 2022 accompanied by a consensus of physicians of different centers in Iran who are experts in the diagnosis and management of this disease. This article considers pathogenesis, epidemiology, clinical manifestations, diagnosis, treatment, and monitoring of MSUD patients with limited recourse.<\/jats:p>","DOI":"10.1186\/s13023-025-03533-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T15:51:17Z","timestamp":1736265077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach"],"prefix":"10.1186","volume":"20","author":[{"given":"Noushin","family":"Rostampour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setila","family":"Dalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Moravej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhila","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Tahereh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zamanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Yahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolhossein","family":"Nikravesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Beyzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ahangar","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahora","family":"Hakemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Talea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"28","key":"3533_CR1","doi-asserted-by":"publisher","first-page":"23397","DOI":"10.1074\/jbc.M112.351031","volume":"287","author":"M Zhou","year":"2012","unstructured":"Zhou M, Gang Lu C, Gao Y, Wang. Haipeng Sun. Tissue-specific and nutrient regulation of the branched-chain \u03b1-keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm). J Biol Chem. 2012;287(28):23397\u2013406.","journal-title":"J Biol Chem"},{"key":"3533_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ymgme.2010.04.007","volume":"100","author":"S Quental","year":"2010","unstructured":"Quental S, Vilarinho L, Martins E, et al. Incidence of maple syrup urine disease in Portugal. Mol Genet Metab. 2010;100:385.","journal-title":"Mol Genet Metab"},{"key":"3533_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0969-2126(00)00105-2","volume":"8","author":"A Aevarsson","year":"2000","unstructured":"Aevarsson A, Chuang JL, Wynn RM, et al. Crystal structure of human branched-chain \u03b1-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure. 2000;8:277\u201391.","journal-title":"Structure"},{"key":"3533_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","volume":"10","author":"PR Blackburn","year":"2017","unstructured":"Blackburn PR, Gass JM, Vairo FPE, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57.","journal-title":"Appl Clin Genet"},{"key":"3533_CR5","unstructured":"Strauss KA, Puffenberger EG, Morton DH. Maple syrup urine disease, 30 January 2006 (updated 9 May 2013). In: Adam MP, Ardinger HH, Pagon RA editors. GeneReviews\u00ae. Seattle, WA: University of Washington, Seattle, 1993\u20132019."},{"key":"3533_CR6","unstructured":"Crawford D. Biological basis of child health 4: an overview of the central nervous system and principles of neurological assessment. Nurs Child Young People. 2022;34(5)."},{"key":"3533_CR7","first-page":"369","volume-title":"\/Acidaemias","author":"M Schiff","year":"2022","unstructured":"Schiff M, Brassier A, Dionisi-Vici C. \/Acidaemias. Inborn Metabolic Diseases: Springer; 2022. pp. 369\u201389."},{"issue":"4","key":"3533_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11011-019-00435-y","volume":"34","author":"M Abiri","year":"2019","unstructured":"Abiri M, Saei H, Eghbali M, Karamzadeh R, Shirzadeh T, Sharifi Z, et al. Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations. Metab Brain Dis. 2019;34(4):1145\u201356.","journal-title":"Metab Brain Dis"},{"key":"3533_CR9","doi-asserted-by":"crossref","unstructured":"Khalifa et al. Genotype\u2013phenotype correlation of 33 patients with maple syrup urine disease. Am J Med Genet. 2020;1\u201315.","DOI":"10.1002\/ajmg.a.61806"},{"key":"3533_CR10","first-page":"639","volume-title":"Child with suspected metabolic disorder","author":"K Pappas","year":"2022","unstructured":"Pappas K, Fabie NAV, Feldman GL. Child with suspected metabolic disorder. Symptom-Based Approach to Pediatric Neurology: Springer; 2022. pp. 639\u201352."},{"issue":"5","key":"3533_CR11","doi-asserted-by":"publisher","first-page":"e1616","DOI":"10.1002\/mgg3.1616","volume":"9","author":"DRR Campanholi","year":"2021","unstructured":"Campanholi DRR, Margutti AVB, Silva WA Jr, Garcia DF, Molfetta GA, Marques AA, Schwartz IVD, Cornejo V, Hamilton V, Castro G, Sperb-Ludwig F, Borges ES, Camelo JS Jr. Molecular basis of various forms of maple syrup urine disease in Chilean patients. Mol Genet Genomic Med. 2021;9(5):e1616.","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"3533_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"DM Frazier","year":"2014","unstructured":"Frazier DM, Allgeier C, Homer C, Marriage BJ, Ogata B, Rohr F, Splett PL, Stembridge A, Singh RH. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab. 2014;112(3):210\u20137.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3533_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/PEC.0000000000001299","volume":"34","author":"LH Rodan","year":"2018","unstructured":"Rodan LH, Aldubayan SH, Berry GT, Levy HL. Acute illness protocol for maple syrup urine disease. Pediatr Emerg Care. 2018;34(1):64\u20137.","journal-title":"Pediatr Emerg Care"},{"key":"3533_CR14","unstructured":"Hassan SA, Gupta V, Maple Syrup Urine D. 2022 Sep 5. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan\u2013."},{"key":"3533_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1542\/peds.109.6.999","volume":"109","author":"Morton","year":"2002","unstructured":"Morton, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109:999\u20131008.","journal-title":"Pediatrics"},{"issue":"6","key":"3533_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10545-017-0083-x","volume":"40","author":"MT Abi-Ward\u00e9","year":"2017","unstructured":"Abi-Ward\u00e9 MT, Roda C, Arnoux JB, et al. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease. J Inherit Metab Dis. 2017;40(6):783\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"3533_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10545-012-9570-2","volume":"36","author":"A Servais","year":"2013","unstructured":"Servais A, Arnoux JB, Lamy C, et al. Treatment of acute decompensation of maple syrup urine disease in adult patients with a new parenteral amino-acid mixture. J Inherit Metab Dis. 2013;36:939\u201344.","journal-title":"J Inherit Metab Dis"},{"key":"3533_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpedi.152.6.593","volume":"152","author":"WL Nyhan","year":"1998","unstructured":"Nyhan WL, Rice-Kelts M, Klein J, Barshop BA. Treatment of the acute crisis in maple syrup urine disease. Arch Pediatr Adolesc Med. 1998;152:593\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"3533_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12937-018-0357-7","volume":"17","author":"SC Gr\u00fcnert","year":"2018","unstructured":"Gr\u00fcnert SC, Rosenbaum-Fabian S, Schumann A, Schwab KO, Mingirulli N, Spiekerkoetter U. Successful pregnancy in maple syrup urine disease: a case report and review of the literature. Nutr J. 2018;17(1):51.","journal-title":"Nutr J"},{"key":"3533_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/ndt\/14.4.910","volume":"14","author":"F Schaefer","year":"1999","unstructured":"Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transpl. 1999;14:910\u20138.","journal-title":"Nephrol Dial Transpl"},{"key":"3533_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00467-001-0801-2","volume":"17","author":"DP Puliyanda","year":"2002","unstructured":"Puliyanda DP, Harmon WE, Peterschmitt MJ, Irons M, Somers MJ. Utility of hemodialysis in maple syrup urine disease. Pediatr Nephrol. 2002;17:239\u201342.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3533_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/hmg\/ddq507","volume":"20","author":"N Brunetti-Pierri","year":"2011","unstructured":"Brunetti-Pierri N, Lanpher B, Erez A, Ananieva EA, Islam M, Marini JC, Sun Q, Yu C, Hegde M, Li J, Wynn RM, Chuang DT, Hutson S, Lee B. Phenylbutyrate therapy for maple syrup urine disease. Hum Mol Genet. 2011;20(4):631\u201340.","journal-title":"Hum Mol Genet"},{"key":"3533_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11940-003-0039-3","volume":"5","author":"KA Strauss","year":"2003","unstructured":"Strauss KA, Morton DH. Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol. 2003;5:329\u201341.","journal-title":"Curr Treat Options Neurol"},{"key":"3533_CR24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00134-001-1124-2","volume":"27","author":"P Jouvet","year":"2001","unstructured":"Jouvet P, Jugie M, Rabier D, Desgres J, Hubert P, Saudubray JM, Man NK. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med. 2001;27:1798\u2013806.","journal-title":"Intensive Care Med"},{"key":"3533_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","volume":"99","author":"KA Strauss","year":"2010","unstructured":"Strauss KA, Wardley B, Robinson D, et al. Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab. 2010;99:333\u201345.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3533_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0151-9638(06)70919-X","volume":"133","author":"I Templier","year":"2006","unstructured":"Templier I, Reymond JL, Nguyen MA, Boujet C, Lantuejoul S, Beani JC, et al. [Acrodermatitis Enteropathica-Like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease]. Ann Dermatol Venereol. 2006;133(4):375\u20139.","journal-title":"Ann Dermatol Venereol"},{"issue":"6","key":"3533_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10545-017-0083-x","volume":"40","author":"M-T Abi-Ward\u00e9","year":"2017","unstructured":"Abi-Ward\u00e9 M-T, Roda C, Arnoux J-B, Servais A, Habarou F, Brassier A, et al. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease. J Inherit Metab Dis. 2017;40(6):783\u201392.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"3533_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jdn.10283","volume":"83","author":"M Deon","year":"2023","unstructured":"Deon M, Guerreiro G, Girardi J, Ribas G, Vargas CR. Treatment of maple syrup urine disease: benefits, risks, and challenges of liver transplantation. Int J Dev Neurosci. 2023;83(6):489\u2013504.","journal-title":"Int J Dev Neurosci"},{"issue":"7694","key":"3533_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0140-6736(71)91041-5","volume":"1","author":"CR Scriver","year":"1971","unstructured":"Scriver CR, Mackenzie S, Clow CL, Delvin E. Thiamine-responsive maple-syrup-urine disease. Lancet (London England). 1971;1(7694):310\u20132.","journal-title":"Lancet (London England)"},{"issue":"3","key":"3533_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-6143.2005.01209.x","volume":"6","author":"KA Strauss","year":"2006","unstructured":"Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, Robinson DL, Hendrickson C, Virji M, Cropcho L, Puffenberger EG, McGhee W, Seward LM, Morton DH. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transpl. 2006;6(3):557\u201364.","journal-title":"Am J Transpl"},{"key":"3533_CR31","doi-asserted-by":"crossref","unstructured":"Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2003;9(8):783\u20138.","DOI":"10.1053\/jlts.2003.50104"},{"issue":"10","key":"3533_CR32","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1073\/pnas.79.10.3300","volume":"79","author":"DT Chuang","year":"1982","unstructured":"Chuang DT, Ku LS, Cox RP. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate. Proc Natl Acad Sci U S A. 1982;79(10):3300\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3533_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2004.11.010","volume":"84","author":"K Heldt","year":"2005","unstructured":"Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab. 2005;84:313\u20136.","journal-title":"Mol Genet Metab"},{"key":"3533_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM199101173240307","volume":"324","author":"GT Berry","year":"1991","unstructured":"Berry GT, Heidenreich R, Kaplan P, Levine F, Mazur A, Palmieri MJ, Yudkoff M, Segal S. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease. N Engl J Med. 1991;324:175\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"3533_CR35","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1007\/s10545-008-0859-0","volume":"31","author":"JY Lee","year":"2008","unstructured":"Lee JY, Chiong MA, Estrada SC, Cutiongco-De la Paz EM, Silao CL, Padilla CD. Maple syrup urine disease (MSUD) \u2014 clinical profile of 47 Filipino patients. J Inherit Metab Dis. 2008;31(2):S281\u20135.","journal-title":"J Inherit Metab Dis"},{"issue":"23","key":"3533_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10545-006-0332-x","volume":"29","author":"A MacDonald","year":"2006","unstructured":"MacDonald A, Depondt E, Evans S, et al. Breastfeeding in IMD. J Inherit Metab Dis. 2006;29(23):299\u2013303.","journal-title":"J Inherit Metab Dis"},{"key":"3533_CR37","doi-asserted-by":"crossref","unstructured":"Shaw V. Clinical pediatric dietetics. Wiley-Blackwell; 2020. Page 537.","DOI":"10.1002\/9781119467205"},{"key":"3533_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jhn.12510","volume":"31","author":"S Evans","year":"2018","unstructured":"Evans S, Daly A, MacDonald J, et al. Fifteen years of using a second stage protein substitute for weaning in phenylketonu- ria: a retrospective study. J Hum Nutr Diet. 2018;31:349\u201356.","journal-title":"J Hum Nutr Diet"},{"key":"3533_CR39","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s10545-006-0276-1","volume":"29","author":"E Simon","year":"2006","unstructured":"Simon E, Flaschker N, Schadewaldt P, et al. Variant maple syrup urine disease (MSUD) \u2013 the entire spectrum. J Inherit Metab Dis. 2006;29:716\u201324.","journal-title":"J Inherit Metab Dis"},{"key":"3533_CR40","first-page":"22","volume":"15","author":"A Kenneson","year":"2018","unstructured":"Kenneson A, Osara Y, Pringle T, et al. Natural history of children and adults with maple syrup urine disease in the NBS-MSUD connect registry. Mol Genet Metab Rep. 2018;15:22\u20137.","journal-title":"Mol Genet Metab Rep"},{"key":"3533_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpeds.2017.05.048","volume":"188","author":"M Evans","year":"2017","unstructured":"Evans M, Truby H, Boneh A. The relationship between dietary intake, growth, and body composition in inborn errors of inter-mediary protein metabolism. J Pediatr. 2017;188:163\u201372.","journal-title":"J Pediatr"},{"key":"3533_CR42","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1046\/j.1365-2133.1998.02415.x","volume":"139","author":"AM Bosch","year":"1998","unstructured":"Bosch AM, Sillevis Smitt JH, Van Gennip AH, et al. Iatrogenic isolated isoleucine deficiency as the cause of an acrodermatitis enteropathica-like syndrome. Br J Dermatol. 1998;139:488\u201391.","journal-title":"Br J Dermatol"},{"key":"3533_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijdevneu.2007.05.004","volume":"25","author":"AG Barschak","year":"2007","unstructured":"Barschak AG, Sitta A, Deon M, et al. Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treat- ment. Int J Dev Neurosci. 2007;25:335\u20138.","journal-title":"Int J Dev Neurosci"},{"key":"3533_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-3476(05)81035-2","volume":"119","author":"GN Thompson","year":"1991","unstructured":"Thompson GN, Francis DE, Halliday D. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. J Pediatr. 1991;119:35\u201341.","journal-title":"J Pediatr"},{"key":"3533_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/archderm.1993.01680240130027","volume":"129","author":"H Northrup","year":"1993","unstructured":"Northrup H, Sigman ES, Hebert AA. Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease. Arch Dermatol. 1993;129:384\u20135.","journal-title":"Arch Dermatol"},{"issue":"6","key":"3533_CR46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10545-012-9570-2","volume":"36","author":"A Servais","year":"2013","unstructured":"Servais A, Arnoux JB, Lamy C, et al. Treatment of acute decompensation of maple syrup urine disease in adult patients with a new parenteral amino-acid mixture. J Inherit Metab Dis. 2013;36(6):939\u201344.","journal-title":"J Inherit Metab Dis"},{"key":"3533_CR47","first-page":"278","volume-title":"Inborn metabolic diseases diagnosis and treatment","author":"HO de Baulny","year":"2012","unstructured":"de Baulny HO, Dionisi-Vici C, Wendel U. Branched\u2010chain organic acidurias\/acidaemias. In: Saudubray JM, van den Berghe G, Walter JH, editors. Inborn metabolic diseases diagnosis and treatment. 5th ed. Berlin: Springer\u2010; 2012. pp. 278\u201396.","edition":"5"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03533-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:40:58Z","timestamp":1736311258000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03533-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03533-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}